Eric received his PharmD from the University of Pittsburgh School of Pharmacy, graduating magna cum laude. He went on to receive his PhD from the Johns Hopkins University School of Medicine under the mentorship of physician-scientist Charlie Rudin. His thesis work focused on using patient-derived models of lung cancer to model genetic and epigenetic mechanisms of acquired resistance to therapies. He joined the Varmus lab for his post-doctoral work in 2018 and is the Kenneth G. and Elaine A. Langone Fellow of the Damon Runyon Cancer Research Foundation (DRG-2343-18)